SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Insite Vision Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bob zagorin who wrote (975)9/28/1999 4:32:00 PM
From: Awashonks  Read Replies (1) of 1060
 
Bob, have you received the analyst report on ISV? It breaks out future products, programs and profits very nicely. It is available from ISV. Just email them and ask them to mail it. Every shareholder should have this report, it is very thorough.

There are several new products, ISV 120 for macular degeneration-Phase I

Varous antibiotic programs that are in negotiations.

The analyst, Warren Beck predicts Calendar 1999 Earnings at .62, 2000 earnings at .29, and 2001 earnings at .48. Not bad. The 99 earnings are high because of milestone payments and perhaps, the 900 deal, as well as reduction in costs in 205.

Sorry it took me so long to respond, I don't visit this board often enough.

Awashonks
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext